Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide

Vaccine

Volumn 22, Issue 7, 2004, Pages 872-879

  Maira Litran, Tomas ^a   Kropec, Andrea ^a   Goldmann, Donald ^b   Pier, Gerald B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Polysaccharide; Staphylococcus; Vaccine

Indexed keywords

ANTIINFECTIVE AGENT; N ACETYLGLUCOSAMINE; POLY N ACETYLGLUCOSAMINE; POLYSACCHARIDE; UNCLASSIFIED DRUG; VACCINE;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIAL STRAIN; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFERENCE PAPER; GENE LOCUS; HOSPITAL INFECTION; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; STAPHYLOCOCCUS AUREUS;

EID: 0842324635     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.11.033     Document Type: Conference Paper

References (77)

1. Sohn A.H., Garrett D.O., Sinkowitz-Cochran R.L., Grohskopf L.A., Levine G.L., Stover B.H.et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J. Pediatr. 139(6):2001;821-827.
2. Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27(5):1999;887-892.
3. Lowy F.D. Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Invest. 111(9):2003;1265-1273.
4. DeLisle S., Perl T.M. Vancomycin-resistant enterococci: a road map on how to prevent the emergence and transmission of antimicrobial resistance. Chest. 123(Suppl 5):2003;504S-518S.
5. Lakshman R., Finn A. Meningococcal serogroup C conjugate vaccine. Expert Opin. Biol. Ther. 2(1):2002;87-96.
6. Pelton S.I. Acute otitis media in an era of increasing antimicrobial resistance and universal administration of pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 21(6):2002;599-604.
7. Obaro S.K. The new pneumococcal vaccine. Clin. Microbiol. Infect. 8(10):2002;623-633.
8. Pozsgay V. Oligosaccharide-protein conjugates as vaccine candidates against bacteria. Adv. Carbohydr. Chem. Biochem. 56:2000;153-199.
9. Barbour M.L., Mayonwhite R.T., Coles C., Crook D.W.M., Moxon E.R. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J. Infect. Dis. 171(1):1995;93-98.
10. Ward J. Prevention of invasive Haemophilus influenzae type-B disease - lessons from vaccine efficacy trials. Vaccine. 9(S):1991;S17-S24.
11. Baker C.J., Paoletti L.C., Wessels M.R., Guttormsen H.K., Rench M.A., Hickman M.E.et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J. Infect. Dis. 179(1):1999;142-150.
12. Campbell W.N., Hendrix E., Cryz S., Cross A.S. Immunogenicity of a 24-valent klebsiella capsular polysaccharide vaccine and an eight-valent pseudomonas o-polysaccharide conjugate vaccine administered to victims of acute trauma. Clin. Infect. Dis. 23(1):1996;179-181.
13. Huebner J., Wang Y., Krueger W.A., Madoff L.C., Martirosian G., Boisot S.et al. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect. Immun. 67(3):1999;1213-1219.
14. Huebner J., Quaas A., Krueger W.A., Goldmann D.A., Pier G.B. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect. Immun. 68(8):2000;4631-4636.
15. Theilacker C., Coleman F., Mueschenborn S., Grout M., Pier G.B. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide/alginate conjugate vaccine. Infect. Immun. 71(7):2003;3875-3884.
16. Hatano K., Pier G.B. Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains. Infect. Immun. 66(8):1998;3719-3726.
17. Fournier J.M., Vann W.F., Karakawa W.W. Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide. Infect. Immun. 45(1):1984;87-93.
18. Sompolinsky D., Samra Z., Karakawa W.W., Vann W.F., Schneerson R., Malik Z. Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types. J. Clin. Microbiol. 22:1985;828-834.
19. Moreau M., Richards J.C., Fournier J.M., Byrd R.A., Karakawa W.W., Vann W.F. Structure of the type-5 capsular polysaccharide of Staphylococcus aureus. Carbohydr. Res. 201(2):1990;285-297.
20. Murthy S.V., Melly M.A., Harris T.M., Hellerqvist C.G., Hash J.H. The repeating sequence of the capsular polysaccharide of Staphylococcus aureus M. Carbohydr. Res. 117:1983;113-123.
21. West T.E., Lewis B.A., Apicella M.A. Immunological characterization of an exopolysaccharide from the Staphylococcus aureus strain Smith diffuse. J. Gen. Microbiol. 133(Pt 2):1987;431-438.
22. Shinefield H., Black S., Fattom A., Horwith G., Rasgon S., Ordonez J.et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. New Engl. J. Med. 346(7):2002;491-496.
23. Lee J.C., Park J.S., Shepherd S.E., Carey V., Fattom A. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect. Immun. 65(10):1997;4146-4151.
24. Naso R., Fattom A. Polysaccharide conjugate vaccines for the prevention of gram-positive bacterial infections. Adv. Exp. Med. Biol. 397:1996;133-140.
25. Welch P.G., Fattom A., Moore J. Jr., Schneerson R., Shiloach J., Bryla D.A.et al. Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis. J. Am. Soc. Nephrol. 7(2):1996;247-253.
26. Fattom A.I., Naso R. Staphylococcal vaccines: a realistic dream. Ann. Med. 28(1):1996;43-46.
27. Fattom A.I., Sarwar J., Ortiz A., Naso R. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect. Immun. 64(5):1996;1659-1665.
28. Tojo M., Yamashita N., Goldmann D.A., Pier G.B. Isolation and characterization of a capsular polysaccharide/adhesin from Staphylococcus epidermidis. J. Infect. Dis. 157:1988;713-722.
29. Kojima Y., Tojo M., Goldmann D.A., Tosteson T.D., Pier G.B. Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter related bacteremia due to coagulase-negative staphylococci. J. Infect. Dis. 162:1990;435-441.
30. Takeda S., Pier G.B., Kojima Y., Tojo M., Muller E., Tosteson T.et al. Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation. 84:1991;2539-2546.
31. Muller E., Takeda S., Shiro H., Goldmann D., Pier G.B. Occurrence of capsular polysaccharide adhesin among clinical isolates of coagulase-negative staphylococci. J. Infect. Dis. 168(5):1993;1211-1218.
32. Mack D., Nedelmann M., Krokotsch A., Schwarzkopf A., Heesemann J., Laufs R. Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin. Infect. Immun. 62(8):1994;3244-3253.
33. Mack D., Fischer W., Krokotsch A., Leopold K., Hartmann R., Egge H.et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-16-linked glucosaminoglycan: purification and structural analysis. J. Bacteriol. 178(1):1996;175-183.
34. McKenney D., Hubner J., Muller E., Wang Y., Goldmann D.A., Pier G.B. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect. Immun. 66(10):1998;4711-4720.
35. McKenney D., Pouliot K.L., Wang Y., Murthy V., Ulrich M., Doring G.et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 284(5419):1999;1523-1527.
36. Maira-Litran T., Kropec A., Abeygunawardana C.et al. Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect. Immun. 70(8):2002;4433-4440.
37. Joyce J.G., Abeygunawardana C., Xu Q., Cook J.C., Hepler R., Przysiecki C.T.et al. Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus. Carbohydr. Res. 338(9):2003;903-922.
38. Baldassarri L., Donelli G., Gelosia A., Voglino M.C., Simpson A.W., Christensen G.D. Purification and characterization of the staphylococcal slime-associated antigen and its occurrence among Staphylococcus epidermidis clinical isolates. Infect. Immun. 64(8):1996;3410-3415.
39. Rupp M.E., Archer G.L. Hemagglutination and adherence to plastic by Staphylococcus epidermidis. Infect. Immun. 60(10):1992;4322-4327.
40. Mack D., Riedewald J., Rohde H., Magnus T., Feucht H.H., Elsner H.A.et al. Essential functional role of the polysaccharide intercellular adhesin of Staphylococcus epidermidis in hemagglutination. Infect. Immun. 67(2):1999;1004-1008.
41. Christensen G.D., Simpson W.A., Bisno A.L., Beachey E.H. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect. Immun. 37(1):1982;318-326.
42. Christensen G.D., Parisi J.T., Bisno A.L., Simpson W.A., Beachey E.H. Characterization of clinically significant strains of coagulase-negative staphylococci. J. Clin. Microbiol. 18(2):1983;258-269.
43. Younger J.J., Christensen G.D., Bartley D.L., Simmons J.C., Barrett F.F. Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: importance of slime production, species identification, and shunt removal to clinical outcome. J. Infect. Dis. 156(4):1987;548-554.
44. Baddour L.M., Smalley D.L., Hill M.M., Christensen G.D. Proposed virulence factors among coagulase-negative staphylococci isolated from two healthy populations. Can. J. Microbiol. 34(7):1988;901-905.
45. Muller E., Huebner J., Gutierrez N., Takeda S., Goldmann D.A., Pier G.B. Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect. Immun. 61(2):1993;551-558.
46. Shiro H., Muller E., Gutierrez N., Boisot S., Grout M., Tosteson T.D.et al. Transposon mutants of Staphylococcus epidermidis deficient in elaboration of capsular polysaccharide/adhesin and slime are avirulent in a rabbit model of endocarditis. J. Infect. Dis. 169:1994;1042-1049.
47. Shiro H., Meluleni G., Groll A., Muller E., Tosteson T.D., Goldmann D.A.et al. The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis. Circulation. 92:1995;2715-2722.
48. Mack D., Siemssen N., Laufs R. Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic adherent Staphylococcus epidermidis - evidence for functional relation to intercellular adhesion. Infect. Immun. 60(5):1992;2048-2057.
49. Heilmann C., Schweitzer O., Gerke C., Vanittanakom N., Mack D., Gotz F. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol. Microbiol. 20(5):1996;1083-1091.
50. Gerke C., Kraft A., Sussmuth R., Schweitzer O., Gotz F. Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J. Biol. Chem. 273(29):1998;18586-18593.
51. Heilmann C., Gerke C., Perdreau-Remington F., Gotz F. Characterization of tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation. Infect. Immun. 64(1):1996;277-282.
52. Cramton S.E., Gerke C., Schnell N.F., Nichols W.W., Gotz F. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect. Immun. 67(10):1999;5427-5433.
53. Fowler V.G. Jr., Fey P.D., Reller L.B., Chamis A.L., Corey G.R., Rupp M.E. The intercellular adhesin locus ica is present in clinical isolates of Staphylococcus aureus from bacteremic patients with infected and uninfected prosthetic joints. Med. Microbiol. Immunol. (Berlin). 189(3):2001;127-131.
54. Arciola C.R., Baldassarri L., Montanaro L. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J. Clin. Microbiol. 39(6):2001;2151-2156.
55. Rohde H., Knobloch J.K., Horstkotte M.A., Mack D. Correlation of Staphylococcus aureus icaADBC genotype and biofilm expression phenotype. J. Clin. Microbiol. 39(12):2001;4595-4596.
56. Vasudevan P., Nair M.K., Annamalai T., Venkitanarayanan K.S. Phenotypic and genotypic characterization of bovine mastitis isolates of Staphylococcus aureus for biofilm formation. Vet. Microbiol. 92(12):2003;179-185.
57. Peacock S.J., Moore C.E., Justice A., Kantzanou M., Story L., Mackie K. et al. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect. Immun. 70(9):2002;4987-4996.
58. Ziebuhr W., Heilmann C., Gotz F., Meyer P., Wilms K., Straube E.et al. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect. Immun. 65(3):1997;890-896.
59. O'Gara J.P., Humphreys H. Staphylococcus epidermidis biofilms: importance and implications. J. Med. Microbiol. 50(7):2001;582-587.
60. Francois P., Tu Quoc P.H., Bisognano C., Kelley W.L., Lew D.P., Schrenzel J.et al. Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis. FEMS Immunol. Med. Microbiol. 35(2):2003;135-140.
61. Patti J.M., Allen B.L., McGavin M.J., Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48:1994;585-617.
62. Wann E.R., Gurusiddappa S., Hook M. The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J. Biol. Chem. 275(18):2000;13863-13871.
63. Foster T.J., Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 6(12):1998;484-488.
64. Christensen G.D., Baddour L.M., Simpson W.A. Phenotypic variation of Staphylococcus epidermidis slime production in vitro and in vivo. Infect. Immun. 55(12):1987;2870-2877.
65. Christensen G.D., Simpson W.A., Bisno A.L., Beachey E.H. Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect. Immun. 40:1983;407-410.
66. Patrick C.C., Plaunt M.R., Hetherington S.V., May S.M. Role of the Staphylococcus epidermidis slime layer in experimental tunnel tract infections. Infect. Immun. 60(4):1992;1363-1367.
67. Patrick C.C., Hetherington S.V., Roberson P.K., Henwick S., Sloas M.M. Comparative virulence of Staphylococcus epidermidis isolates in a murine catheter model. Pediatr. Res. 37(1):1995;70-74.
68. Deighton M.A., Borland R., Capstick J.A. Virulence of Staphylococcus epidermidis in a mouse model: significance of extracellular slime. Epidemiol. Infect. 117(2):1996;267-280.
69. Perdreau-Remington F., Sande M.A., Peters G., Chambers H.F. The abilities of a Staphylococcus epidermidis wild-type strain and its slime-negative mutant to induce endocarditis in rabbits are comparable. Infect. Immun. 66(6):1998;2778-2781.
70. Ulphani J.S., Rupp M.E. Model of Staphylococcus aureus central venous catheter-associated infection in rats. Lab. Anim. Sci. 49(3):1999;283-287.
71. Rupp M.E., Ulphani J.S., Fey P.D., Mack D. Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect. Immun. 67(5):1999;2656-2659.
72. Rupp M.E., Fey P.D., Heilmann C., Gotz F. Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J. Infect. Dis. 183(7):2001;1038-1042.
73. Gelosia A., Baldassarri L., Deighton M., van Nguyen T. Phenotypic and genotypic markers of Staphylococcus epidermidis virulence. Clin. Microbiol. Infect. 7(4):2001;193-199.
74. Jefferson K.K., Cramton S.E., Gotz F., Pier G.B. Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR. Mol. Microbiol. 48(4):2003;889-899.
75. McKenney D, Pouliot KL, Maira-Litran T, Kropec A, Cramton SE, Goetz F, et al. Abstracts of the 101st General Meeting of the American Society for Microbiology, Abstract D-44. 2001. p. 284.
76. Maira-Litran T, Kropec A, Pier GB. Abstracts of the 103rd General Meeting of the American Society for Microbiology, Abstract E-121. 2002.
77. Kropec AP, Briggs S, Pier GB. Abstracts of the 103rd General Meeting of the American Society for Microbiology, Abstract E-117. 2002.